<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1358553</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Molecular pathogenesis of <italic>Chlamydia trachomatis</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jury</surname>
<given-names>Brittany</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fleming</surname>
<given-names>Charlotte</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huston</surname>
<given-names>Wilhelmina M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/386267"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Luu</surname>
<given-names>Laurence Don Wai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/550560"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Life Sciences, Faculty of Science, University of Technology Sydney</institution>, <addr-line>Ultimo, NSW</addr-line>, <country>Australia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Faculty of Science, University of Technology Sydney</institution>, <addr-line>Ultimo, NSW</addr-line>, <country>Australia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Scot P Ouellette, University of Nebraska Medical Center, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Laurence Don Wai Luu, <email xlink:href="mailto:laurence.luu@uts.edu.au">laurence.luu@uts.edu.au</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1358553</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Jury, Fleming, Huston and Luu</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Jury, Fleming, Huston and Luu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fcimb.2023.1281823" ext-link-type="doi">A Corrigendum on <article-title>Molecular pathogenesis of <italic>Chlamydia trachomatis</italic>
</article-title> by Jury B, Fleming C, Huston WM and Luu LDW (2023) <italic>Front. Cell. Infect. Microbiol.</italic> 13:1281823. doi:&#xa0;<object-id>10.3389/fcimb.2023.1281823</object-id>
</related-article>
<kwd-group>
<kwd>
<italic>Chlamydia trachomatis</italic>
</kwd>
<kwd>pathogenesis</kwd>
<kwd>virulence</kwd>
<kwd>immune evasion</kwd>
<kwd>type III secretion system</kwd>
<kwd>proteases</kwd>
<kwd>cytotoxin</kwd>
<kwd>polymorphic membrane proteins</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="724"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Clinical Microbiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there were errors in some sections of the text where we referred to the wrong gene, citation or did not clearly articulate previous findings. These are detailed below:</p>
<p>A correction has been made to <bold>Section 2 Transcription and regulatory factors as a target to understand pathogenesis, paragraph 3</bold> where we said phase-locked &#x3c3;<sup>54</sup> mutants were used instead of CtcC mutants to investigate the transcriptional profiles for the &#x3c3;<sup>54</sup> regulon.</p>
<p>This sentence previously stated:</p>
<p>
<italic>&#x201c;Recently, transcriptional profiles for the &#x3c3;<sup>54</sup> regulon was generated using a phase-locked &#x3c3;<sup>54</sup> mutant which further revealed the role of this sigma factor in membrane remodelling and incorporating T3SS effectors into EBs during RB differentiation into infectious EB progeny (Soules et&#xa0;al., 2020).&#x201d;</italic>
</p>
<p>The correct sentence appears below:</p>
<p>
<italic>&#x201c;Recently, transcriptional profiles for the &#x3c3;<sup>54</sup> regulon was generated using CtcC (an ATP-hydrolyzing response regulator for &#x3c3;<sup>54</sup>) mutants which further revealed the role of this sigma factor in membrane remodelling and incorporating T3SS effectors into EBs during RB differentiation into infectious EB progeny (Soules et&#xa0;al., 2020).&#x201d;</italic>
</p>
<p>A correction has been made to <bold>Section 3.3 Inc proteins, paragraph 1 and 3</bold> where we erroneously referred to IncS instead of CTL0390 and we have provided further clarity on previous findings on Inc proteins.</p>
<p>This section previously stated:</p>
<p>
<italic>&#x201c;Inc proteins, or inclusion membrane proteins, are characterised by the presence of SNARE-like motifs in their coding sequence and have a diversity of functions. &#x201c;&#x2026;&#x201d;IncA is required for inclusion vacuole fusion</italic> (Table&#xa0;1B)<italic>, other functions of Inc proteins include; host cell viability (IncG), establishing infection (IncD) and promoting replication (IncV).&#x201d; &#x2026;&#x201d;Here, we focus on recent IncM, IncS and CpoS which have been recently characterised.&#x201d;</italic>
</p>
<p>
<italic>&#x201c;The IncS effector is important for mediating EB exit via host-cell lysis during the late stages. IncS regulates Golgi translocation and activation of STING, which is needed for host-cell lysis and bacterial exit at the correct development stage for typical growth (Bishop and Derr&#xe9;, 2022).&#x201d;</italic>
</p>
<p>The corrected section appears below:</p>
<p>
<italic>&#x201c;Inc proteins or inclusion membrane proteins, share bilobed hydrophobic domains enabling anchoring to the inclusion membrane. Some Incs contain the presence of vesicle-targeting SNARE-like motifs in their coding sequence (e.g. IncA), which may facilitate host-pathogen interactions (Cingolani et&#xa0;al., 2019; Paumet et&#xa0;al., 2009).&#x201d;&#x2026;&#x201d;IncA is required for inclusion vacuole fusion</italic> (<bold>Table&#xa0;1B</bold>
)<italic>, other functions of Inc proteins include; a possible role in maintaining host cell viability (IncG) (Scidmore and Hackstadt, 2001; Verbeke et&#xa0;al., 2006) and as an early Inc, IncD may be important for establishing the inclusion as a replicative niche (Shaw et&#xa0;al., 2000), although further studies are required to confirm this.&#x201d;&#x2026;&#x201d;Here, we focus on IncM, CTL0390 and CpoS which have been recently characterised.&#x201d;</italic>
</p>
<p>
<italic>&#x201c;The CTL0390 Inc effector is thought to play a role in mediating EB exit via host-cell lysis during the late stages. A CTL0390 mutant was observed to have reduced Golgi translocation of STING, which is likely required to regulate host-cell lysis for bacterial exit (Bishop and Derr&#xe9;, 2022).&#x201d;</italic>
</p>
<p>A correction has been made to <bold>Section 3.4 ChlaDUB, paragraph 1</bold> where the sentence erroneously stated that ChlaDUB1 has been shown to stabilize GLUT-1 and GLUT-3, but the referenced study only showed ChlaDUB1 stabilizes GLUT-1.</p>
<p>This sentence previously stated:</p>
<p>
<italic>&#x201c;ChlaDUB1 also prevents degradation of host glucose-transporter-1 (GLUT-1) and GLUT-3 proteins (Wang et&#xa0;al., 2017). This likely supports growth as knockdown of host GLUT-1, GLUT-3 and adolase A impairs C. trachomatis infection (Wang et&#xa0;al., 2017).&#x201d;</italic>
</p>
<p>The corrected sentence appears below:</p>
<p>
<italic>&#x201c;ChlaDUB1 also prevents degradation of host glucose-transporter-1 (GLUT-1) proteins (Wang et&#xa0;al., 2017). This likely supports growth as knockdown of host GLUT-1 impairs C. trachomatis infection (Wang et&#xa0;al., 2017).&#x201d;</italic>
</p>
<p>A correction has also been made to <bold>Section 6 Plasmid, paragraph 1</bold> where the sentence erroneously stated pGP3 as a transcriptional regulator instead of pGP4.</p>
<p>This sentence previously stated:</p>
<p>
<italic>&#x201c;pGP3, is a master transcriptional regulator of both plasmid and chromosomal genes (Turman et&#xa0;al., 2023).&#x201d;</italic>
</p>
<p>The corrected sentence appears below:</p>
<p>
<italic>&#x201c;pGP4, is a putative transcriptional regulator of both plasmid and chromosomal genes (Turman et&#xa0;al., 2023).&#x201d;</italic>
</p>
<p>The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>